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randomised study design
Anne Looijmans1*, Frederike Jörg2,3, Robert A Schoevers2, Richard Bruggeman2, Ronald P Stolk1
and Eva Corpeleijn1Abstract
Background: Severe mentally ill (SMI) patients have a reduced life expectancy of 13–30 years compared to the
general population, largely due to an increased risk of cardiovascular mortality. Unhealthy lifestyle behaviours in SMI
patients contribute to this increased risk. The obesogenic living environment of patients in residential facilities may
even pose an extra risk. Although several studies have shown positive effects of lifestyle interventions on SMI
patients’ weight status, studies including residential patients and their obesogenic environment are scarce. This
paper describes the Effectiveness of Lifestyle Interventions in PSychiatry trial (ELIPS). The goal of this trial is to
improve cardiometabolic health in severe mentally ill residential patients by addressing the obesogenic
environment.
Methods/design: The ELIPS study is a multi-site cluster randomised controlled trial (RCT) based on the principles of
a pragmatic RCT. All residential and long-term clinical care teams of two large mental health care organisations in
the North of the Netherlands serving SMI patients are invited to participate. The intervention is aimed at team level.
Lifestyle coaches first develop a team specific lifestyle plan that tailors the ELIPS goals and protocol and then train
teams on how to create a healthy environment and stimulate healthy behaviours in patients. After three months,
teams take over the intervention after they have set out goals to achieve in the following nine months. In this
phase, adherence to the lifestyle plan and pre-set goals is monitored. Patients in the control arm receive care as
usual. Primary outcome measure is waist circumference at three and 12 months after baseline.
Discussion: ELIPS is different from previously published lifestyle intervention studies in three ways. First, it follows
the principles of a pragmatic design, which enables the examination of effects in everyday practice. Second, by
implementing the intervention at team level, we expect lifestyle activities to be maintained when interventionists
leave. Last, by targeting the obesogenic environment we create a prerequisite for any sustainable health
improvement, as patients can only make healthy choices in a healthy living environment.
Trial registration: Nederlands Trialregister NTR2720 (Dutch Trial Register, www.trialregister.nl). Registered 27
January 2011.
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The life expectancy of patients with severe mental illness
(SMI) is 13–30 years less than that of the general popu-
lation [1]. This is largely due to an increased risk of car-
diometabolic disease, including type 2 diabetes and
cardiovascular disease. High rates of smoking, poor diet-
ary habits, a sedentary lifestyle and side effects of type of
antipsychotic medication are all modifiable risk factors
that contribute to the increased mortality [2,3]. Numer-
ous studies have investigated the effectiveness of lifestyle
interventions in SMI patients [4-8]. These included sin-
gle group interventions, non-randomized controlled tri-
als and randomized controlled trials (RCTs). Although
most studies are small and vary in their methodological
quality, they all show that lifestyle interventions are feas-
ible in SMI patients and can lead to weight loss and im-
provements in cardiometabolic health [9]. Mean weight
losses across studies by treatment duration were 2.63 kg
for 12- to 16-week interventions, 4.24 kg for 6-month
interventions and 3.05 kg for 12- to 18-month interven-
tions according to Gabriele et. al. [10].
In the current literature, lifestyle intervention studies
in SMI residential patients are scarce. In their systematic
review on exercise interventions for mentally ill inpa-
tients, Stanton and Happell [11] found eight small stud-
ies with sample sizes varying from 12 to 39 patients. The
somatic health of SMI patients living in residential facil-
ities is not better than in SMI outpatients [11,12]. More-
over, residential patients’ living environment may pose
an extra risk, as a lack of daily activities and an abundant
provision of unhealthy food products may lead to an
obesogenic environment. Swinburn et. al. [13] conceptu-
alized the role of the obesogenic living environment as
“the sum of influences that the surroundings, opportun-
ities, or conditions of life have on promoting obesity in
individuals or populations” (p. 564). Residential facilities
seldom offer vocational rehabilitation activities, sports or
physical activities, and residential patients are usually
not involved in housekeeping chores. Patients may be of-
fered meals from a central kitchen that are not always
based on healthy nutrition guidelines, and snacks and
other unhealthy food products are often readily available.
It seems inefficient, and even unethical, to motivate pa-
tients to adopt a healthy lifestyle in an environment that
stimulates unhealthy behaviour. While the obesogenic
elements in residential patients’ living environment may
play an important role in the development of weight
gain, they yield possibilities for prevention and weight
reduction as well. As far as we know, only one small
intervention study (N = 37 at 12-month measure) aimed
to tackle the obesogenic environment of patients [14].
Besides the focus on the obesogenic environment and
the residential SMI population, our trial has another fea-
ture distinguishing it from other studies in SMI patients,and that is the so called ‘small change approach’. Large ini-
tial weight loss has been associated with greater weight
gain later on [15]. Furthermore, even when weight loss is
low (≤3%), lifestyle changes such as aerobic exercise can
have beneficial effects on cardiometabolic risk factors such
as insulin resistance, elevated blood lipids, blood pressure
and glucose metabolism [16]. And last, smaller lifestyle
changes are more likely to be sustainable, leading to in-
creased health gain in the long run. In a small RCT,
Sbrocco et. al. (1999) compared a small change approach
in eating behaviour to a traditional behavioural weight loss
program [17]. Initially, participants of the traditional pro-
gram lost more weight than the small change group, but
after nine months, the small change group continued to
lose weight while the traditional behavioural therapy
group started to regain weight. These results have been
replicated recently in a US veterans study where small
changes in both nutrition and physical activity led to
weight loss and maintenance [18]. As far as we know, this
small change approach has not been carried out in studies
involving SMI patients, while they would particularly
benefit from this approach considering the cognitive defi-
cits and negative symptoms that are characteristic of this
patient group.
Until now, most high quality lifestyle intervention
studies in SMI patients have been RCTs. While a trad-
itional measurement-blinded RCT is the preferred de-
sign to evaluate the efficacy of a lifestyle intervention, it
also has important disadvantages. Often the most moti-
vated patients are (unintentionally) selected for a trial in
a laboratory setting. It has been shown that these pa-
tients are usually not comparable to patients in real-life
settings [19]. Additionally, in a traditional RCT, lifestyle
interventions are often strictly organised and supervised
by interventionists, whereas in daily practice “health
care interventions are seldom given under such circum-
stances”. (p. 2) [20]. The lack of external validity poses a
threat to the effectiveness of interventions in daily prac-
tice, with not-so-motivated patients and without the
dedicated attention of interventionists. For this reason,
we designed a RCT with a pragmatic character to evalu-
ate the effectiveness of a lifestyle intervention in a real-
life setting with local staff members [20].
The aim of the current paper is to give a detailed por-
trayal of a clustered randomised controlled trial evaluating
the effectiveness of a lifestyle intervention, the Effective-
ness of Lifestyle Interventions in PSychiatry trial (ELIPS).
This combined diet and physical activity lifestyle interven-
tion is designed to improve the obesogenic environment
of SMI residential patients. It is hypothesised that chan-
ging the obesogenic environment by engaging patients in
physical activities and offering them the choice for healthy
products, will improve cardiometabolic health in this
patient group.
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ELIPS is a multi-site trial designed according to the princi-
ples of a pragmatic RCT to allow evaluation of the inter-
vention in real-life care facilities. Details are described
below according to the CONSORT statement for cluster
randomised trials [21] and the extension of the CON-
SORT statement for pragmatic trials [22]. The Medical
Ethical Committee for Research in Mental Health Care
(Metigg) approved the study protocol. The trial is regis-
tered in the Dutch Trial Registry (Nederlands Trialregister
NTR2720, www.trialregister.nl. Registered 27 January 2011).
Participants
All residential and long-term clinical care teams of two
large mental health organisations in the North of the
Netherlands, a catchment area of 1.2 million inhabitants,
are invited to participate in the study (N = 30). One resi-
dential team exclusively serving patients suffering from
Korsakov’s syndrome is excluded. Team leaders are in-
formed by an invitation letter followed by a meeting to
explain the study. Teams are visited by the project leader
to explain the aims of the study and answer questions.
Teams serve severe mentally ill patients, often with a
diagnosis of schizophrenia or other psychotic disorder,
most of whom have been living in residential facilities
for at least 10 years. Caseload sizes vary from 20 to 65
patients per team. In the Netherlands, patients living in
residential facilities live as independently as possible,
with a team of professionals nearby. Patients are housed
alone or in small groups in a community neighbour-
hood. Long-term clinical care facilities provide more in-
tensive professional care and assistance in activities of
daily living. Housing is provided in the sheltered and
safe environment of the mental health care organisation.
All patients are invited to participate, as they are all at
increased risk of unhealthy lifestyle habits due to their
obesogenic living environment, and all patients are consid-
ered to have an increased cardiometabolic risk. Exclusion
criteria are age below 18, pregnancy and being unable to
perform physical activity tests (e.g. wheelchair user). Pa-
tients not taking part in the yearly routine outcome moni-
toring (ROM, see ‘outcomes’), that is used for this study to
monitor intervention effects, will not be included in the
analysis. In the mental health organisation Lentis (~50%
recruitment area) only patients using antipsychotic medi-
cation are routinely monitored. Therefore, patients from
Lentis not using antipsychotic medication are excluded.
Intervention
The ELIPS intervention is aimed at team level and focuses
on achieving established ELIPS lifestyle goals. These goals
are: 1. At least two physical activities per week, of which at
least one moderately intensive; 2. At least three changes
in daily food supply that favour health; 3. A weekly foodworkshop, in which patients learn to buy, cook and eat
healthy food products; 4. A sustainable change in the obe-
sogenic environment on organisation level. The ELIPS
goals and subgoals are presented in Table 1. The interven-
tion is implemented by lifestyle coaches; each team has
two lifestyle coaches at its disposal. Before the start, life-
style coaches receive two days of intensive training which
consists of lectures and interactive sessions on SMI and its
symptoms (positive and negative psychotic symptoms, de-
pression), metabolism, healthy food products, physical ac-
tivities suitable for SMI patients, motivational interviewing,
the development over time of the obesogenic environment
and ways to tackle it.
The trial consists of a preparation phase, an imple-
mentation phase and a monitoring phase. An overview
of phase-specific tasks is given below. The team specific
interventions are outlined in the one-month prepar-
ation phase. During this period, lifestyle coaches be-
come acquainted with team members, patients and the
location. The coaches screen which healthy and un-
healthy behaviours and lifestyle activities take place and
seek possibilities for improvement that comply to the
ELIPS goals. To increase activity participation and sus-
tainability, lifestyle coaches make a list of activities that
patients and team members find appealing. Structured
protocols describe planning of lifestyle activities (i.e.
minimal two physical activities and one food workshop
per week) and form the basis of each intervention to
insure that team specific interventions are compatible
and all teams pursue the ELIPS lifestyle goals. The team
specific lifestyle plan includes a detailed program of ex-
ercise and food activities according to the ELIPS goals
and is adjusted to the team’s opportunities, patients’
preferences and the logistic possibilities of the location.
This tailor-made lifestyle plan colours this pragmatic
cluster randomised trial.
Description of tasks and schedule of ELIPS intervention:
-1 - 0 months Preparation phase
– Lifestyle coaches visit intervention teams to become
acquainted with the team, patients and location.
– Lifestyle coaches explore which (un)healthy
behaviours and activities take place.
– Lifestyle coaches inquire which lifestyle activities
patients and teams prefer and examine logistic
possibilities for these activities.
– Lifestyle coaches create a team-specific lifestyle plan
based on ELIPS lifestyle goals, structured protocols
and the preferences and possibilities of the team
and patients.
– Baseline measures: ROM-nurses carry out ROM
measurements, research assistants carry out
additional measures. See Table 2 for an overview
of measurements.
Table 1 Lifestyle goals of ELIPS intervention and examples from practice
Goal Subgoal and example
1. Minimally two physical activities per week, one of them being intensive
1.1 increase in daily physical activity on individual level
E.g. counselling conversations during a walk outside rather than sitting in the office; patients walk/cycle to shop
for own groceries; patients walk/cycle to work rather than taking the bus.
1.2 increase in daily physical activity on group level (low intensity)
E.g. organise group walks one or twice a week.
1.3 participation in more intensive physical group activity (organised, medium intensity)
E.g. organise a weekly football activity, organise a WII-sports activity, visit a fitness centre once a week, go for a swim once per two weeks.
2. Minimally three improvements in food supply
2.1 decrease in intake of saturated fat and trans fatty acids
E.g. replace high-fat cheese by low-fat cheese; limit consumption of sweetened dairy products; limit cake consumption
(luxury cookies only on Sundays).
2.2 increase in intake of fibres
E.g. replace white bread by whole wheat bread; replace white rice/pasta by whole rice/pasta; serve fruit and vegetables during activities.
2.3 decrease in energy intake
E.g. replace products by light versions; replace butter by (diet) margarine; replace almond paste cake by gingerbread.
2.4 decrease in intake of salt
E.g. buy fresh vegetables instead of canned vegetables; replace crisps by vegetables (cucumber); offer snacks in small portions,
and/or only in the weekends.
3. Minimal one food focused activity per week
E.g. create a daily fruit moment; make a shopping list together; buy healthy groceries together; cook a healthy meal together;
play a food quiz; make smoothies; learn to decipher the list of ingredients.
4. Adjustment of the obesogenic environment on organisational level
E.g. limit access to food cupboards, adjust food supply in canteen (selling fried snacks only twice per week); provide a gym; set up contracts with
fitness centres; purchase a WII sports; prepare breakfast every morning; put nutrition and physical activity standard on the team meeting’s agenda.
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– Lifestyle coaches organise lifestyle activities and
workshops. The team is involved in the organisation
and motivates patients to participate. Lifestyle
coaches first demonstrate the activities, then
co-organise them out together with the team, while
towards the end, they supervise team members who,
over time, are made responsible for carrying out the
lifestyle activities themselves.
– Lifestyle coaches transfer their knowledge and skills
of healthy behaviours to the team.
– Lifestyle coaches assist the team in setting concrete
goals in order to improve or maintain a healthier
lifestyle after the lifestyle coaches have gone.
– Structural changes to adjust the obesogenic
environment are explored and implemented.
3 - 12 months Monitoring phase
– 3-months measures: ROM-nurses carry out ROM
measurements, research assistants carry out
additional measures. See Table 2 for an overview of
measurements.
– Team continues lifestyle activities, aiming to achieve
the pre-defined goals.– Start monthly monitoring visits. A lifestyle coach
evaluates with the team the pre-defined goals,
detects obstacles in achieving these goals, solves
observed obstacles. If necessary, recommendations
for improvements are made.
– 12-months measures: ROM-nurses carry out ROM
measurements, research assistants carry out
additional measures. See Table 2 for an overview of
measurements.
– 12-months monitoring visit: final monitoring
wherein goals are evaluated and recommendations
are made to sustain the lifestyle activities.
In the three months intervention phase the team specific
intervention is implemented. Lifestyle coaches first dem-
onstrate the activities, then carry out the activities together
with team members and finally supervise while team
members carry out the activities themselves. During the
entire implementation phase, lifestyle coaches train teams
how to create a healthy environment for their patients and
stimulate a healthier lifestyle in their patients. Lifestyle
coaches transfer their knowledge and skills to the team
members by demonstrating exercise and food activities as
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stimulate patients to adopt a healthier lifestyle. Exercise
activities are for instance walking, low-intensity sports
such as jeu de boules, badminton, table tennis, bicycling.
The intensity and frequency of the exercises will gradually
increase. Food workshops could be for example cooking a
vegetable soup together with patients, making smoothies,
teaching how to read a list of ingredients, demonstrating
the amount of sugar in soft drinks and juices and doing af-
fordable fruit and vegetable shopping in the market place
together. Examples of adjusting the environment are
restricting access to food cupboards, setting up contracts
with local gyms, placing fruit on the table. More practical
examples are presented in italics in Table 1. At the end of
the three months implementation period, the team sets
goals to achieve in the following 9 months. During this
9 month monitoring phase a lifestyle coach visits all inter-
vention teams monthly and will discuss with the team and
team leader whether goals are achieved, if there are any
barriers in achieving the goals and look for ways to re-
move the obstacles.
The intervention has two distinct features that are not
described in lifestyle interventions presented in the lit-
erature [9]. First, the intervention is implemented at
team level. We hypothesise that team members will be
able to induce the largest change in their patients’ life-
style behaviours as they already have a relationship with
patients. Moreover, it will be easier to continue healthy
lifestyle activities after the intervention period, when
these activities are imbedded in the team and in the
team’s schedule. Also, team members might become
stimulated to adjust their own lifestyle as well and in
doing so, set a good example. The second distinct fea-
ture of the intervention is the focus on changing the
obesogenic environment. Stimulating patients to engage
in healthy lifestyle behaviour can only be a success when
the environment offers sufficient possibilities for healthy
lifestyle choices. Sport facilities and exercise activities
must be available, as well as healthy food products. Like-
wise, the environment can discourage unhealthy behav-
iours, for instance by narrowing the opening hours of
canteens serving fried snacks. It is hypothesised that an
intervention with these distinct features will lead to
changes in lifestyle behaviour in patients that are highly
sustainable.
Control group
The patients in the control arm receive care as usual. No
ELIPS lifestyle intervention activities will be carried out in
the control teams. Teams or individual team members are
not prohibited to discuss healthy lifestyle behaviours with
their patients or organise healthy lifestyle activities. All
healthy lifestyle activities will be documented and new ini-
tiatives are reported to the researchers. When ethicallyand logistically possible, researchers will ask teams to
delay implementation of these activities until the end of
the study. Monitoring visits by lifestyle coaches will estab-
lish possible changes in intensity or frequency of existing
lifestyle activities during the study.
Objectives
The primary objective is to determine the effect of the
ELIPS intervention on body fatness defined by waist cir-
cumference at 3 and 12 months. We hypothesise that
the ELIPS intervention group will have a reduced or sta-
bilized waist circumference whereas the waist circumfer-
ence of the control group will increase. The secondary
objective is to determine the effect of the ELIPS inter-
vention on other cardiometabolic risk factors, i.e. blood
pressure, lipids and glucose metabolism. Furthermore, the
aim is to determine the effect of the ELIPS intervention
on lifestyle behaviours (physical fitness, physical activity,
dietary habits), mental health (positive and negative psych-
otic symptoms, depressive symptoms), quality of life and
psycho-social functioning of patients. For all these objec-
tives, the difference in effect across age groups and gender
will be studied. In view of the pragmatic trial, a process
evaluation on the degree and quality of the implementation
of the intervention and changes at team and organisation
level is foreseen. The outcomes of this evaluation will be
used to investigate differences in effectiveness between
teams. Lastly, the effect of the ELIPS intervention is investi-
gated in terms of cost-effectiveness. The cost-effectiveness
of lifestyle interventions has not been researched in severe
mentally ill residential patients and this study will give an
indication of the costs related to health improvements in
this population.
Outcomes
Measurements are performed on patient and team level.
A detailed description of the measures is given below and
an overview of all measurements is given in Table 2. The
measurements will be performed at baseline and three and
twelve months after the start of the intervention. A large
part of the measurements are performed routinely as part
of standard care. These Routine Outcome Monitoring
(ROM) screenings are implemented in all mental health
care organisations in the North of the Netherlands.
Trained nurses visit patients yearly after individual ap-
pointments have been made or schedules are set up by
team coordinators. Results are recorded in the patient rec-
ord form and discussed with the patient. When ROM
screenings were first implemented, patients were asked for
informed consent to use their ROM data for research pur-
poses. Only anonimized data are used for scientific re-
search, and the procedure was approved by the Medical
Ethical Committee of the University Medical Center
Groningen. For the ELIPS data collection, two regular,
Table 2 ELIPS Trial measurements overview
Baseline 3 months Monthly, during
monitoring phase
12 months
Measurements on patient level
General information Age, gender, birth year, diagnoses, year of first psychosis X
Physical measures Height X X X
Weight X X X
Waist circumference X X X
Blood pressure (systolic, diastolic, pulse) X X X
Body fat (%)* X X X
Lab test Lipids (Total cholesterol, LDL-cholesterol,
HDL-cholesterol, triglycerides)
X X X
Glucose metabolism (glucose, HbA1c) X X X
Clinical parameters (CRP, ASAT, ALAT, urea,
creatinin, TSH, leukocytes)
X X X
Psychological measures CDSS X X X
PANSS X X X
HoNOS X X X
MANSA X X X
Lifestyle habits Functional physical fitness X X X
(six-minute walk test)*
Daily physical activity (SQUASH)* X X X
Food frequency questionnaire (adapted to patient population)
Cost-effectiveness Dutch care consumption questionnaire* X X X
SF6D* X X X
Measurements on team level
General information Age, gender, birth year, level of education,
number of years working in psychiatry, function*
X X X
Process evaluation Semi-structured interview team leader* X X X** X
Semi-structured interview staff* X X X** X
Semi-structured interview patients* X X X** X
Observatory list* X X X** X
Staff questionnaire Knowledge on diet and physical activity,
attitude towards lifestyle changes in patients,
self-efficacy in addressing lifestyle issues with patients*
X X X
*Measurement is not part of ROM screening. Additional measures are collected by research assistants.
**Measures are collected at intervention teams only.
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12 months follow up) and an additional ROM screening
will be carried out at three months for which patients
receive a small participation fee (€5,00).
Some measurements are not part of ROM and will be
carried out by research assistants, mostly the lifestyle
coaches. Research assistants will receive one day training
to study protocols and procedures and to practice asses-
sing the functional physical fitness in patients with the
six-minute walk test, assessing the body fat percentage
with the Bioelectrical impedance analysis, measuring
height and weight, assessing food habits with a food
questionnaire based on Dutch guidelines for a healthydiet which is adapted to this population, and question-
naires and interviews with patients and staff for process
evaluation. All measurements will be taken on site or in
a location that is familiar to the patient (e.g. patient’s
own room, nurses’ office). Research assistants contact
patients directly to set up an appointment or staff mem-
bers act as intermediaries to facilitate setting up appoint-
ments. Appointments for interviews with staff members
are scheduled by research assistants and staff members.
Measurements on patient level
Patient measurements include cardiometabolic health, dis-
ease history, medication use, mental health, psychosocial
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tion and general information (i.e. age, gender).
Cardiometabolic health. The physical measurements
include waist circumference, height, weight, pulse and
systolic and diastolic blood pressure. Patients visit a
(hospital) laboratory that collects a blood sample, if pos-
sible in fasting state for levels of lipids (total cholesterol,
LDL-cholesterol, HDL-cholesterol and triglycerides),
glucose metabolism (glucose, HbA1c) and clinical pa-
rameters (i.e. CRP, ALAT, ASAT, urea, creatinine, TSH,
leukocytes) and vitamin D status. Measurements are
taken following standard ROM protocols. Waist circum-
ference is measured in duplicate using a flexible non-
stretching tape halfway between the iliac crest and
lowest rib in standing position at the end of an expir-
ation. Weight is measured by calibrated scales (Seca,
model 813) in light clothing without shoes or jackets.
Measurements for height will be available from multiple
measurements of both ROM nurses and research assis-
tants. The highest height will be used unless patients
wear shoes, then the highest height without shoes is
used. Pulse and systolic and diastolic blood pressure are
measured after 5 minutes’ rest in sitting position, using a
blood pressure monitor (BOSO medicus control). Body
fat percentage is measured in standing position [23] by
bioelectrical impedance analysis (BIA) in triplicate using
a single-frequency bioimpedance analyzer (Model BIA
101, AKERN Srl, Italy) [24,25].
Mental health. During an interview, trained nurses ad-
minister the PANSS (Positive and Negative Syndrome
Scale, [26]) and the CDSS (Calgarary Depression Scale
for Schizophrenia, [27]). Prior to the interview, patients
fill in the MANSA, a self-report questionnaire about pa-
tients’ Quality of Life [28] and uncertainties can be dis-
cussed during the interview. The HoNOS (Health of the
Nations Outcome Scale, [29]) is an observation scale of
psycho-social functioning and is scored by the case man-
ager or team.
Lifestyle habits. Functional physical fitness is assessed by
research assistants with a detailed protocol for the six-
minute walk test [30], which contains standard phrases
and time points for encouragement and has been validated
in patients with schizophrenia [31]. The intraclass correl-
ation coefficient was 0.96. Although a mild practice effect
was detected for a three-day interval, this is unlikely to
persist for a three–month interval. The test is conducted
indoors. Patient staff is allowed to walk along with patients
if necessary. Daily physical activity is assessed using the
Dutch validated SQUASH questionnaire [32]. Nutritional
habits are estimated using a semi-quantitative food fre-
quency questionnaire with items based on a screening
questionnaire for healthy eating habits of the Netherlands
Nutrition Center according to the Dutch guidelines for a
healthy diet [33] and adapted to this population. Thequestionnaire will be used to assess changes in dietary
habits on food group level. It is not specifically validated
in SMI patients and can and will not be used to derive
quantitative estimates of total energy, macro- or micronu-
trient intake.
Cost-effectiveness parameters. Care consumption is
estimated with the Dutch care consumption question-
naire [34], which is adapted to the context of the current
study. Quality adjusted life years (QALYs) will be the pri-
mary outcome measure in the cost-effectiveness analysis.
In order to estimate QALYs, utility scores will be derived
from the SF12, using the SF6D algorithm [35,36].
Measurements on team level
Measurements at team level include lifestyle knowledge
and attitudes from staff, level of support of team man-
agers, and process evaluation. Mental health care profes-
sionals are asked to fill in questionnaires for process
evaluation and staff characteristics as potential determi-
nants of successful intervention at baseline, and three
and 12 months after start of the intervention.
Process evaluation. One research assistant visits all
teams (both control and intervention) and will interview
the team leader, staff and patients separately, using semi-
structured interviews, at baseline, three months and
12 months to determine which lifestyle activities are ini-
tiated and sustained. These measurements are in
addition to the monthly monitoring visits that have a
more advisory character. The interviews contain ques-
tions on organisational aspects (e.g. is anyone in the
team specifically responsible for the lifestyle activities
and if yes state name) as well as on lifestyle-related ac-
tivities. These activities will be reported in great detail
(what is being organised, for how long, how often, how
many participants from the housing facility participate,
and more). Questions, translated from Dutch, are for ex-
ample “How many times per week are physically inten-
sive activities offered?”, “What have you changed in food
supply?”, “What type of food workshops have you orga-
nised?” and “Are patients stimulated to do household
chores?”. During these visits, the research assistant will
screen kitchen cabinets, refrigerator and shared living
rooms to determine the level of ‘obesogenic environ-
ment’ (e.g. fruit on the table, healthy products in store
or products with reduced fat and energy in the cabinets
and refrigerator, number of exercise activities written in
the team’s calendar). The information is combined to es-
tablish adherence to the lifestyle plan and the degree
and quality of implementation of the intervention.
Mental health professionals’ characteristics. Data on
age, education and experience are collected at baseline.
At baseline, and three and 12 months after the start of
the intervention, at least three members of the team will
be asked to fill in questionnaires to rate their knowledge
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changes in patients, and self-efficacy in addressing life-
style issues with patients (Staff questionnaire). The ques-
tionnaire is developed based on existing questionnaires
from the Netherlands Nutrition Center to evaluate life-
style knowledge. Questions on attitude and self-efficacy
are based on the ACE-model, better known as the ASE-
model. This model describes the relationship between a
persons’ attitudes, social influences and self-efficacy, and
his or her behaviour. Questions are adapted to fit the
study design and patient group [37,38].
Sample size
The primary objective in this study is to detect a differ-
ence in waist circumference with clinical significance.
Sample size calculations show that to detect a significant
change of −5% waist circumference [39] (alpha =0.05,
power 0.90), 219 patients are needed in both interven-
tion and control arm. Research in psychiatric patients
usually shows a high drop-out rate. However, since in
this project patients are living intramurally and most
measurements are part of standard care, it is expected that
the drop-out rate, once having signed an informed con-
sent, will not exceed 10%. Therefore the target number of
patients to include in both intervention and control arm is
240 (N = 219 + 10% drop-out). In both mental health orga-
nisations together, approximately 1000 eligible SMI pa-
tients live in residential or long-term clinical care facilities.
Results from a pilot study show that two thirds of patients
will successfully participate in the measurements which
means that the two organisations will suffice to include
the necessary 240 patients per arm. This number will also
be sufficient to demonstrate for example a 4.7% reduction
in plasma glucose. The clustered nature of the trial re-
quires some extra thoughts on loss of power in multilevel
analyses. However, as we a have a large number of clusters
(13 clusters; see below) and a large number of patients per
cluster (range from 44 to 130), the interdependency of ob-
servations will be limited. This may justify using individual
patient rather than clustered sample size calculations [40].
Randomisation
After recruitment, teams are randomised to intervention
or control condition. To ensure comparability of teams
in the intervention and control arm, clusters of compar-
able teams are made based on health care organisation,
level of intensity of care (long-term residential or long-
term clinical care), caseload size and location (urban or
rural). Each cluster consists of two comparable teams in
terms of these variables; one cluster contains five com-
parable teams. Of each cluster, the teams are randomly
allocated to one of the two conditions by a computerised
random number generator. A research nurse not in-
volved in the study reveals the results of the allocation.All participating teams are randomised simultaneously
making allocation sequence concealment unnecessary.
Blinding of teams and patients to the allocation condi-
tion is not possible due to the nature of the intervention.
Research nurses assessing the outcomes in the ROM
screenings are blinded to the intervention allocation.
The research assistants taking the six-minute walk test,
body fat test and lifestyle questionnaires in patients and
staff are not blinded to the intervention at the baseline
and 3 months measurements. Outcome measures at
12 months after baseline are however carried out by dif-
ferent research assistants that are not informed of the
allocation status of the teams and patients. All post-
intervention measures at 12 months after start of the
intervention will thus be obtained blinded.
Statistical methods
Data will be analysed with intent-to-treat analysis be-
cause all patients within intervention teams are expected
to be exposed in some extent to the adjusted obesogenic
environment. A multi-level linear mixed model will be
used in order to evaluate the effect of intervention group
on waist circumference at 3 and 12 months after base-
line, with intervention group (i.e. belonging to an inter-
vention or control team) being the main independent
variable. The model accounts for the clustering of teams
and the longitudinal character of the trial. Adjustments for
baseline scores will be made and interactions with age and
gender will be studied. Secondary outcomes, other cardio-
metabolic risk factors, lifestyle behaviours, mental health,
quality of life and psycho-social functioning, will be ana-
lysed in the same way as waist circumference.
The number of achieved ELIPS goals, the degree of
additional changes in the environment, the stability of
teams, and knowledge, attitudes and self-efficacy of
teams and team leaders towards a healthy lifestyle will
be scored to give insight in the variation and quality of
implementation of the intervention per team. Subgroup
analyses will be done to find out if there are differences
in outcomes between patients within teams with more
of less successful implementation of the intervention.
This might also give an idea of minimal conditions
needed for this intervention to be implemented to a cer-
tain degree.
An economic evaluation will be conducted to assess the
cost-effectiveness of the lifestyle intervention compared to
care as usual in severe mentally ill residential patients. The
analysis will be performed from a societal perspective;
costs in and outside the healthcare sector will be included.
Results will be expressed in terms of incremental costs per
percentage change in waist circumference. Furthermore, a
cost-utility analysis will be conducted with the QALY
(Quality Adjusted Life Years) as primary outcome meas-
ure. Finally, potential long-term economic consequences
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cular diseases will be explored.
Missing data and drop-outs will be analysed and
accounted for by multiple imputation if the assumption
of data missing at random (MAR) is not violated.
Discussion
Several diet and physical activity interventions have suc-
cessfully improved cardiometabolic health in SMI pa-
tients [9]. However, large randomised controlled trials
studying lifestyle interventions in residential patients are
lacking, even though these patients might be more vul-
nerable for unhealthy lifestyle behaviours due to an obe-
sogenic living environment. To our knowledge, only one
study addressed the environment of patients with
schizophrenia or schizoaffective disorder hospitalised for
one year or longer [14]. Staff members were involved in
this study and results show no significant differences in
BMI between intervention and control patients after
12 months. However, the sample size of this study was
small with 37 patients included in the 12 months
measures.
The distinctive features of the ELIPS trial compared to
other lifestyle interventions in SMI patients are the focus
on modifying the obesogenic environment of residential
patients and the implementation of the intervention on
team level. Changing the obesogenic environment is ex-
pected to have long-term effects on patients’ health due
to the sustainable character of these changes. Interven-
tions that include modification of the environment to
stimulate healthy behaviour show positive results: there
is potential for improving dietary habits on the work site
[41] and, combined with education, it leads to improve-
ments in dietary habits and waist circumference in men
with substance addictions in residential settings [42].
Implementing the intervention on team level is expected
to lead to maintenance of health behaviours after the
intervention stops. In the study of Álvarez-Jiménez and
colleagues [43] a three month behavioural intervention led
to less weight gain in first-episode psychosis patients com-
pared to controls, but this effect had diminished three
months after the intervention ended. The ACHIEVE trial
[8] showed significant weight reduction 18 months after
the start of a lifestyle intervention in overweight and obese
SMI patients. However, during this 18 month period sev-
eral aspects of the intervention, such as individual visits
and physical activity classes, were led by the intervention-
ists. This increases the costs of the intervention and it re-
mains to be seen whether the weight loss is maintained
when the sessions led by interventionists stop. Most ex-
perts in the obesity field argue that the key to successful
stabilisation of new behaviours is long-term treatment
[44]. ELIPS will implement the intervention on team level,
by coaching team members in creating a healthy livingenvironment for their patients and in stimulating them to
adopt healthy lifestyles. As the intervention is applied in
daily routine and fits in the team’s schedule, it is expected
that the effect of the intervention maintains when lifestyle
coaches leave.
A strength of the inclusion on team level is that pa-
tient selection bias is decreased. Patients are automatic-
ally invited to participate, except when they meet the
exclusion criteria (age <18, pregnancy or being unable to
perform physical activity tests). The target sample is
large with in total approximately 1000 eligible patients.
The multi-site character of the trial with all 29 eligible
teams in the North of the Netherlands being invited, the
setting of teams in both urban and rural areas, and the
number of eligible patients per team will lead to the in-
clusion of most of the SMI residential patients in the
North of the Netherlands. This representative sample,
together with the implementation of the intervention in
real-life settings, emphasises the generalisability of the
results of the ELIPS trial.
Advantages of using measures conducted as part of
standard care are the reduced costs and the limited impact
on patients. Measurements taken during the ROM screen-
ing (PANSS, CDSS, HoNOS and MANSA) are widely vali-
dated. Currently, feasible and validated methods to assess
dietary intake in SMI patients, however, are lacking. It will
be quite a challenge to adapt and validate a widely applic-
able method to reliably assess dietary intake in SMI pa-
tients, considering their cognitive deficits.
When randomisation is successful, both conditions
will consist of teams that are and teams that are not
already interested in or acquainted with healthy life-
style matters. Although patients in the control teams
receive care as usual, some of these teams might be or
become active in offering lifestyle activities and in
stimulating healthy behaviours in their patients, even
at baseline [45]. Therefore, in both conditions, all life-
style activities are evaluated at baseline, and at three
and twelve months follow up. In the control condition,
teams are kindly requested to discuss new or planned
initiatives with the researchers to see if delay of initia-
tives is possible. Baseline patient characteristics are
checked to ensure comparability of patients in control
and intervention teams. If necessary, corrections for
baseline differences will be made during analysis.
ELIPS is a lifestyle intervention aiming to improve car-
diometabolic health in severe mentally ill residential pa-
tients by adjusting the obesogenic environment. If the
ELIPS intervention proves to be successful, the results
will have large external validity as it is performed in a
real-life setting with a representative sample. By tackling
the obesogenic environment of long-term residential pa-
tients, we expect to achieve an improved health status
that can be maintained.
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